Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProPhase Labs, Inc. - Common Stock (NQ: PRPH )

0.6055 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,117
Open 0.6055
Bid (Size) 0.5720 (5)
Ask (Size) 0.6051 (22)
Prev. Close 0.6055
Today's Range 0.6055 - 0.6055
52wk Range 0.5600 - 7.480
Shares Outstanding 18,045,209
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
US Stocks Mixed; Fluor Earnings Miss Views
Via Benzinga
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga

Performance

YTD
-31.19%
-31.19%
1 Month
-11.73%
-11.73%
3 Month
-73.50%
-73.50%
6 Month
-81.54%
-81.54%
1 Year
-87.89%
-87.89%

More News

Read More
Why Upstart Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt
Via Benzinga
ProPhase Labs's Earnings: A Preview
Via Benzinga
ProPhase Labs Earnings Preview
Via Benzinga
Analyst Expectations for ProPhase Labs's Future
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
ProPhase Labs's Earnings: A Preview
Via Benzinga
S&P 500 Tops 6,000; Sezzle Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Tops 44,000; US Consumer Sentiment Increases In November
Via Benzinga
Topics Stocks
Exposures US Equities
Why ProPhase Labs (PRPH) Stock Is Down 47% Today
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
PRPH Stock Earnings: ProPhase Labs Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
PRPH Stock Earnings: ProPhase Labs Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 15, 2024
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
DSS, Inc.'s (NYSE American: DSS) Subsidiary Appoints New Chief Investment Officer To Aggressively Develop Mutual Fund Business For Eventual Spinoff
Via Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
Via News Direct
Earnings Scheduled For August 10, 2023
Via Benzinga
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
Via TheNewswire.com
DSS Inc. Is Spinning Off Its Biotech Subsidiary After Signing A Major Licensing Agreement
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.